Literature DB >> 25604264

Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.

Valery Adorno-Cruz1, Golam Kibria1, Xia Liu1, Mary Doherty1, Damian J Junk1, Dongyin Guan2, Chris Hubert3, Monica Venere4, Erin Mulkearns-Hubert5, Maksim Sinyuk5, Alvaro Alvarado5, Arnold I Caplan6, Jeremy Rich7, Stanton L Gerson8, Justin Lathia9, Huiping Liu10.   

Abstract

With the goal to remove the roots of cancer, eliminate metastatic seeds, and overcome therapy resistance, the 2014 inaugural International Cancer Stem Cell (CSC) Conference at Cleveland, OH, convened together over 320 investigators, including 55 invited world-class speakers, 25 short oral presenters, and 100 poster presenters, to gain an in-depth understanding of CSCs and explore therapeutic opportunities targeting CSCs. The meeting enabled intriguing discussions on several topics including: genetics and epigenetics; cancer origin and evolution; microenvironment and exosomes; metabolism and inflammation; metastasis and therapy resistance; single cell and heterogeneity; plasticity and reprogramming; as well as other new concepts. Reports of clinical trials targeting CSCs emphasized the urgent need for strategically designing combinational CSC-targeting therapies against cancer. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25604264      PMCID: PMC4359955          DOI: 10.1158/0008-5472.CAN-14-3225

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression.

Authors:  Steven T Sizemore; Ruth A Keri
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 2.  The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Authors:  Mark P Chao; Irving L Weissman; Ravindra Majeti
Journal:  Curr Opin Immunol       Date:  2012-02-04       Impact factor: 7.486

3.  The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Authors:  Yinxing Liu; Misty R Gilbert; Natasha Kyprianou; Vivek M Rangnekar; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2014-08-19       Impact factor: 17.088

4.  Luminal cells are favored as the cell of origin for prostate cancer.

Authors:  Zhu A Wang; Roxanne Toivanen; Sarah K Bergren; Pierre Chambon; Michael M Shen
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

5.  Epigenetic targeting of ovarian cancer stem cells.

Authors:  Yinu Wang; Horacio Cardenas; Fang Fang; Salvatore Condello; Pietro Taverna; Matthew Segar; Yunlong Liu; Kenneth P Nephew; Daniela Matei
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

6.  Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors.

Authors:  Antonia Patsialou; Jose Javier Bravo-Cordero; Yarong Wang; David Entenberg; Huiping Liu; Michael Clarke; John S Condeelis
Journal:  Intravital       Date:  2013-04-01

7.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Joyce Huan Chen; Lihua Wang; Jewell Walters; Yong Jun Shin; Julian P Goerger; Jian Sun; Mavee Witherspoon; Nikolai Rakhilin; Jiahe Li; Herman Yang; Jeff Milsom; Sang Lee; Warren Zipfel; Moonsoo M Jin; Zeynep H Gümüş; Steven M Lipkin; Xiling Shen
Journal:  Cell Stem Cell       Date:  2013-05-02       Impact factor: 24.633

8.  Regulation of myeloid leukaemia by the cell-fate determinant Musashi.

Authors:  Takahiro Ito; Hyog Young Kwon; Bryan Zimdahl; Kendra L Congdon; Jordan Blum; William E Lento; Chen Zhao; Anand Lagoo; Gareth Gerrard; Letizia Foroni; John Goldman; Harriet Goh; Soo-Hyun Kim; Dong-Wook Kim; Charles Chuah; Vivian G Oehler; Jerald P Radich; Craig T Jordan; Tannishtha Reya
Journal:  Nature       Date:  2010-07-18       Impact factor: 49.962

Review 9.  Tumour heterogeneity and cancer cell plasticity.

Authors:  Corbin E Meacham; Sean J Morrison
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  103 in total

1.  miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.

Authors:  Ravand Samaeekia; Valery Adorno-Cruz; Jessica Bockhorn; Ya-Fang Chang; Simo Huang; Aleix Prat; Nahun Ha; Golam Kibria; Dezheng Huo; Hui Zheng; Rachel Dalton; Yuhao Wang; Grigoriy Y Moskalenko; Huiping Liu
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

Review 2.  Cancer stem cells and exosome signaling.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Stem Cell Investig       Date:  2015-06-02

3.  Oxidative stress induces senescence in breast cancer stem cells.

Authors:  Guangxian Zhong; Shenghui Qin; Danyelle Townsend; Bradley A Schulte; Kenneth D Tew; Gavin Y Wang
Journal:  Biochem Biophys Res Commun       Date:  2019-05-17       Impact factor: 3.575

Review 4.  The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.

Authors:  Meis Moukayed; William B Grant
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

5.  MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.

Authors:  Aimin Yang; Shenghui Qin; Bradley A Schulte; Stephen P Ethier; Kenneth D Tew; Gavin Y Wang
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

Review 6.  New Opportunities and Challenges to Defeat Cancer Stem Cells.

Authors:  Erika K Ramos; Andrew D Hoffmann; Stanton L Gerson; Huiping Liu
Journal:  Trends Cancer       Date:  2017-09-21

7.  Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.

Authors:  Yichao Wang; Xiaolin Wang; Yu Zhang; Lan Yu; Bo Zhu; Shiwu Wu; Danna Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 8.  AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

Authors:  Bowen Yan; David Claxton; Suming Huang; Yi Qiu
Journal:  Exp Hematol       Date:  2020-06-20       Impact factor: 3.084

9.  New Advances and Challenges of Targeting Cancer Stem Cells.

Authors:  Nurmaa K Dashzeveg; Rokana Taftaf; Erika K Ramos; Luke Torre-Healy; Anastasia Chumakova; Daniel J Silver; Tyler J Alban; Maksim Sinyuk; Praveena S Thiagarajan; Awad M Jarrar; Soumya M Turaga; Caner Saygin; Erin Mulkearns-Hubert; Masahiro Hitomi; Jeremy N Rich; Stanton L Gerson; Justin D Lathia; Huiping Liu
Journal:  Cancer Res       Date:  2017-09-19       Impact factor: 12.701

Review 10.  Cancer stem cells: a potential target for cancer therapy.

Authors:  Hong Qiu; Xiaoguang Fang; Qi Luo; Gaoliang Ouyang
Journal:  Cell Mol Life Sci       Date:  2015-05-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.